Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy

2019 2018 Stancu, 2001, Statins: mechanism of action and effects, J Cell Mol Med, 5, 378, 10.1111/j.1582-4934.2001.tb00172.x Farwell, 2011, Statins and prostate cancer diagnosis and grade in a veterans population, J Natl Cancer Inst, 103, 885, 10.1093/jnci/djr108 Lustman, 2014, Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study, Prostate Cancer Prostat Dis, 17, 6, 10.1038/pcan.2013.34 Moyad, 2005, Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer, Urology, 66, 1150, 10.1016/j.urology.2005.08.053 Park, 2013, Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis, Ann Oncol, 24, 1427, 10.1093/annonc/mdt077 Allott, 2014, Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the shared equal access regional cancer hospital (SEARCH) database, BJU Int, 114, 661, 10.1111/bju.12720 Carroll, 2013, PSA testing for pretreatment staging and posttreatment management of prostate cancer: 2013 revision of 2009 best practice statement, AUA Educ Res Inc, 1 Opie, 2015, Present status of statin therapy, Trends Cardiovasc Med, 25, 216, 10.1016/j.tcm.2014.10.002 Zhong, 2015, Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies, Cancer Treat Rev, 41, 554, 10.1016/j.ctrv.2015.04.005 Devaraj, 2007, Statins and biomarkers of inflammation, Curr Atheroscler Rep, 9, 33, 10.1007/BF02693938 Rao, 2010, To JUPITER and beyond: statins, inflammation, and primary prevention, Crit Care (Lond), 14, 10.1186/cc9006 Liu, 2014, Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis, Asian J Androl, 16, 467, 10.4103/1008-682X.123686 Oesterle, 2017, Pleiotropic effects of statins on the cardiovascular system, Circ Res, 120, 229, 10.1161/CIRCRESAHA.116.308537 Antoniades, 2011, Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling, Circulation, 124, 335, 10.1161/CIRCULATIONAHA.110.985150 Insull, 2009, The pathology of atherosclerosis: plaque development and plaque responses to medical treatment, Am J Med, 122, S3, 10.1016/j.amjmed.2008.10.013 Nielsen, 2012, Statin use and reduced cancer-related mortality, N Engl J Med, 367, 1792, 10.1056/NEJMoa1201735 Wang, 2016, Statin use and all-cancer survival: prospective results from the Women's Health Initiative, Br J Cancer, 115, 129, 10.1038/bjc.2016.149 Rao, 1999, Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase, Proc Natl Acad Sci U S A, 96, 7797, 10.1073/pnas.96.14.7797 Hoque, 2008, Statin induces apoptosis and cell growth arrest in prostate cancer cells, Cancer Epidemiol Biomarkers Prev, 17, 88, 10.1158/1055-9965.EPI-07-0531 Crick, 1998, Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells, J Neurochem, 70, 2397, 10.1046/j.1471-4159.1998.70062397.x Demierre, 2005, Statins and cancer prevention, Nat Rev Cancer., 5, 930, 10.1038/nrc1751 Murai, 2015, Cholesterol lowering: role in cancer prevention and treatment, Biol Chem, 396, 1, 10.1515/hsz-2014-0194 Lee, 2013, Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1, Cancer Res, 73, 1211, 10.1158/0008-5472.CAN-12-3128 Alfaqih, 2017, The current evidence on statin use and prostate cancer prevention: are we there yet?, Nat Rev Urol., 14, 107, 10.1038/nrurol.2016.199 Ishola, 2017, Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-gamma and cyclo-oxygenase-2, Fundam Clin Pharmacol, 31, 652, 10.1111/fcp.12301 Hsieh, 2016, Rosuvastatin decreases testosterone levels but not sexual function in men with type 2 diabetes, Diabetes Res Clin Pract, 120, 81, 10.1016/j.diabres.2016.07.026 Yu, 2014, Use of statins and the risk of death in patients with prostate cancer, J Clin Oncol, 32, 5, 10.1200/JCO.2013.49.4757